Marijuana Stock Movers For March 16, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 21.45% at $0.02
Cannabis Stock Movers For March 15, 2022
GAINERS:
Rhinomed (OTC:RHNMF) shares closed up 35.71% at $0.19
Cannabis Stock Gainers And Losers From March 7, 2022
GAINERS:
Nine Energy Service (NYSE:NINE) shares closed up 100.00% at $3.60
cbdMD And GNC Partnership Expanded With 11 More CBD Products Like Gummies, Sleep Aids, And Softgels
cbdMD, Inc. (NYSE: YCBD) has expanded in product offerings online and in over 840 retail GNC Holdings, LLC stores nationwide.
cbdMD Expands Product Offering And Nationwide Footprint With Major Retail Partner GNC
cbdMD, Inc. (NYSE:YCBD, YCBDpA)))), (the "Company") one of the world's leading and most highly trusted and recognized health & wellness CBD companies, has announced an expansion in product offerings
Global Cannabis Stock Index Falls, Nearly But Not Quite Breaking 11-Month Losing Streak
The Global Cannabis Stock Index fell for the 12th consecutive month, declining 1.1% to 28.31, reported Alan Brochstein, founder of New Cannabis Ventures and 420 Investor.
INDYCAR Driver & NASCAR Champion Jimmie Johnson Joins cbdMD As Brand Ambassador
cbdMD, Inc. (NYSE: YCBD) (NYSE: YCBDPA) has entered into an endorsement agreement with 7-time NASCAR Cup Series (NCS) Champion and current NTT INDYCAR SERIES driver Jimmie Johnson as a strategic brand ambassador in the marketplace
CbdMD Requests FDA Remove Drug Exclusion For CBD And Examine Its Safety Submission
Natural Products Association filed a Citizen's Petition on cbdMD's (NYSE: YCBD) behalf with the Food and Drug Administration (FDA) requesting it remove the drug exclusion for CBD and review the company's extensive dossier of identity, safety and quality data.</
78 Biggest Movers From Friday
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.
Recap: cbdMD Q1 Earnings
cbdMD (AMEX:YCBD) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:10 PM.
Here's what investors need to know about the announcement.
Earnings
cbdMD missed estimated earnings by 300.0%, reporting an EPS of $-0.08 versus an estimate of $-0.02.